AI English summary of an SEC filing — figures as filed
Crown Castle CCICrown Castle said it entered into sales agreements on March 20, 2024 with BofA Securities, Barclays Capital and other sales agents under which it may issue and sell common stock from time to time, with an aggregate gross sales price of up to $750,000,000 and a par value of $0.01 per share.
Key points
AI summaryCrown Castle said it entered into sales agreements on March 20, 2024 with BofA Securities, Barclays Capital and other sales agents under which it may issue and sell common stock from time to time, with an aggregate gross sales price of up to $750,000,000 and a par value of $0.01 per share.
The company said the sales agents will use commercially reasonable efforts to sell the shares on its behalf, and that sales will be made through ordinary brokers' transactions on the New York Stock Exchange or otherwise at prevailing market prices, at prices related to market prices, or at negotiated prices under its instructions. It said it may also sell shares to any sales agent as principal, in which case it will enter into a separate terms agreement.
The company said the shares will be sold under its Form S-3 shelf registration statement (Registration No. 333-277989). It said actual sales will depend on a variety of factors determined by the company from time to time.
The company said the Prior Offering under its separate sales agreements, dated March 19, 2021, has been terminated, and that no common stock was sold under the Prior Offering.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Crown Castle Enters Up to $750,000,000 Common Stock Sales Agreements
Crown Castle said it entered into sales agreements on March 20, 2024 with BofA Securities, Barclays Capital and other sales agents under which it may issue and sell common stock from time to time, with an aggregate gross sales price of up to $750,000,000 and a par value of $0.01 per share.
Source · Based on the filing body and exhibits
Sales Agent Execution Method and Principal Sales
The company said the sales agents will use commercially reasonable efforts to sell the shares on its behalf, and that sales will be made through ordinary brokers' transactions on the New York Stock Exchange or otherwise at prevailing market prices, at prices related to market prices, or at negotiated prices under its instructions. It said it may also sell shares to any sales agent as principal, in which case it will enter into a separate terms agreement.
Source · Based on the filing body and exhibits
Sales Under Form S-3 Shelf Registration Statement
The company said the shares will be sold under its Form S-3 shelf registration statement (Registration No. 333-277989). It said actual sales will depend on a variety of factors determined by the company from time to time.
Source · Based on the filing body and exhibits
Prior Offering Terminated as of March 19, 2021
The company said the Prior Offering under its separate sales agreements, dated March 19, 2021, has been terminated, and that no common stock was sold under the Prior Offering.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…